Total runs:
31.5K
Run Growth:
-8.5K
Growth Rate:
-26.87%
Sponsored by
APIMart
FreedomIntelligence / Apollo-7B-GGUF
Model's Last Updated: April 29 2024
Introduction of Apollo-7B-GGUF
Model Details of Apollo-7B-GGUF
Multilingual Medicine: Model, Dataset, Benchmark, Code
Covering English, Chinese, French, Hindi, Spanish, Hindi, Arabic So far
👨🏻💻
Github
•📃
Paper
• 🌐
Demo
• 🤗
ApolloCorpus
• 🤗
XMedBench
中文
|
English
🌈 Update
- [2024.04.28] We have updated multiple versions of the Apollo-7B GGUF model.
- [2024.03.07] Paper released.
- [2024.02.12] ApolloCorpus and XMedBench is published！🎉
- [2024.01.23] Apollo repo is published！🎉
Overview
| Type | Size/GB | Notes |
|---|---|---|
| Q2_K | 3.6 | |
| IQ3_XS | 3.9 | |
| IQ3_S | 4.1 | beats Q3_K* |
| Q3_K_S | 4.1 | |
| IQ3_M | 4.2 | |
| Q3_K_M | 4.5 | lower quality |
| Q3_K_L | 4.8 | |
| IQ4_XS | 4.9 | |
| Q4_K_S | 5.1 | fast, recommended |
| Q4_K_M | 5.4 | fast, recommended |
| Q5_K_S | 6.1 | |
| Q5_K_M | 6.2 | |
| Q6_K | 7.1 | very good quality |
| Q8_0 | 9.2 | fast, best quality, but very large |
Results
🤗 Apollo-0.5B • 🤗 Apollo-1.8B • 🤗 Apollo-2B • 🤗 Apollo-6B • 🤗 Apollo-7B
🤗 Apollo-0.5B-GGUF • 🤗 Apollo-2B-GGUF • 🤗 Apollo-6B-GGUF • 🤗 Apollo-7B-GGUF
Dataset & Evaluation
-
Dataset 🤗 ApolloCorpus
Click to expand
-
-
Pretrain:
-
data item:
-
json_name: {data_source} {language} {data_type}.json
-
data_type: medicalBook, medicalGuideline, medicalPaper, medicalWeb(from online forum), medicalWiki
-
language: en(English), zh(chinese), es(spanish), fr(french), hi(Hindi)
-
data_type: qa(generated qa from text)
-
data_type==text: list of string
[ "string1", "string2", ... ] -
data_type==qa: list of qa pairs(list of string)
[ [ "q1", "a1", "q2", "a2", ... ], ... ]
-
-
-
SFT:
-
json_name: {data_source}_{language}.json
-
data_type: code, general, math, medicalExam, medicalPatient
-
data item: list of qa pairs(list of string)
[ [ "q1", "a1", "q2", "a2", ... ], ... ]
-
-
-
Evaluation 🤗 XMedBench
Click to expand
-
EN:
- MedQA-USMLE
- MedMCQA
- PubMedQA : Because the results fluctuated too much, they were not used in the paper.
-
MMLU-Medical
- Clinical knowledge, Medical genetics, Anatomy, Professional medicine, College biology, College medicine
-
ZH:
- MedQA-MCMLE
-
CMB-single
: Not used in the paper
- Randomly sample 2,000 multiple-choice questions with single answer.
-
CMMLU-Medical
- Anatomy, Clinical_knowledge, College_medicine, Genetics, Nutrition, Traditional_chinese_medicine, Virology
-
CExam
: Not used in the paper
- Randomly sample 2,000 multiple-choice questions
-
ES: Head_qa
-
FR: Frenchmedmcqa
-
HI: MMLU_HI
- Clinical knowledge, Medical genetics, Anatomy, Professional medicine, College biology, College medicine
-
AR: MMLU_Ara
- Clinical knowledge, Medical genetics, Anatomy, Professional medicine, College biology, College medicine
-
Results reproduction
Click to expand
Waiting for Update
Acknowledgment
We sincerely thank mradermacher for the assistance in providing multiple versions of the Apollo-7B GGUF model!
Citation
Please use the following citation if you intend to use our dataset for training or evaluation:
@misc{wang2024apollo,
title={Apollo: Lightweight Multilingual Medical LLMs towards Democratizing Medical AI to 6B People},
author={Xidong Wang and Nuo Chen and Junyin Chen and Yan Hu and Yidong Wang and Xiangbo Wu and Anningzhe Gao and Xiang Wan and Haizhou Li and Benyou Wang},
year={2024},
eprint={2403.03640},
archivePrefix={arXiv},
primaryClass={cs.CL}
}
Runs of FreedomIntelligence Apollo-7B-GGUF on huggingface.co
399
Total runs
0
24-hour runs
-16
3-day runs
-31
7-day runs
62
30-day runs
More Information About Apollo-7B-GGUF huggingface.co Model
Url of Apollo-7B-GGUF
Apollo-7B-GGUF huggingface.co Url
Provider of Apollo-7B-GGUF huggingface.co
Other API from FreedomIntelligence
Updated:January 17 2026
Total runs:
2.8K
Run Growth:
2.0K
Growth Rate:
68.76%
Total runs:
1.5K
Run Growth:
287
Growth Rate:
19.59%
Total runs:
1.4K
Run Growth:
0
Growth Rate:
0.00%
Total runs:
1.4K
Run Growth:
-15
Growth Rate:
-1.10%
Total runs:
788
Run Growth:
154
Growth Rate:
19.54%
Total runs:
785
Run Growth:
113
Growth Rate:
14.39%
Total runs:
756
Run Growth:
-34
Growth Rate:
-4.50%
Total runs:
717
Run Growth:
517
Growth Rate:
72.11%
Total runs:
713
Run Growth:
186
Growth Rate:
26.09%
Total runs:
643
Run Growth:
410
Growth Rate:
63.76%
Total runs:
601
Run Growth:
0
Growth Rate:
0.00%
Total runs:
375
Run Growth:
4
Growth Rate:
1.07%
Total runs:
336
Run Growth:
65
Growth Rate:
20.38%
Total runs:
318
Run Growth:
299
Growth Rate:
94.03%
Total runs:
278
Run Growth:
261
Growth Rate:
96.31%
Total runs:
274
Run Growth:
126
Growth Rate:
45.99%
Total runs:
270
Run Growth:
140
Growth Rate:
51.85%
Total runs:
257
Run Growth:
67
Growth Rate:
26.17%
Total runs:
245
Run Growth:
60
Growth Rate:
24.49%
Total runs:
240
Run Growth:
234
Growth Rate:
97.50%
Total runs:
227
Run Growth:
-153
Growth Rate:
-66.23%
Total runs:
218
Run Growth:
-258
Growth Rate:
-118.35%
Total runs:
202
Run Growth:
161
Growth Rate:
79.70%
Total runs:
196
Run Growth:
60
Growth Rate:
30.61%
Total runs:
189
Run Growth:
91
Growth Rate:
48.92%
Total runs:
172
Run Growth:
102
Growth Rate:
59.30%
Total runs:
172
Run Growth:
9
Growth Rate:
5.26%
Total runs:
170
Run Growth:
119
Growth Rate:
70.83%
Total runs:
169
Run Growth:
84
Growth Rate:
50.30%
Total runs:
161
Run Growth:
-301
Growth Rate:
-186.96%
Total runs:
161
Run Growth:
114
Growth Rate:
70.81%
Total runs:
152
Run Growth:
-242
Growth Rate:
-159.21%
Total runs:
134
Run Growth:
110
Growth Rate:
82.09%
Total runs:
132
Run Growth:
55
Growth Rate:
41.67%
Total runs:
120
Run Growth:
-11
Growth Rate:
-8.94%
Total runs:
115
Run Growth:
0
Growth Rate:
0.00%
Total runs:
111
Run Growth:
0
Growth Rate:
0.00%
Total runs:
103
Run Growth:
1
Growth Rate:
0.97%
Total runs:
102
Run Growth:
79
Growth Rate:
77.45%
Total runs:
101
Run Growth:
-79
Growth Rate:
-78.22%
Total runs:
98
Run Growth:
-13
Growth Rate:
-12.50%
Total runs:
96
Run Growth:
26
Growth Rate:
27.08%
Total runs:
91
Run Growth:
-29
Growth Rate:
-30.53%
Total runs:
88
Run Growth:
44
Growth Rate:
50.00%
Total runs:
84
Run Growth:
-70
Growth Rate:
-81.40%
Total runs:
83
Run Growth:
51
Growth Rate:
61.45%
Total runs:
81
Run Growth:
47
Growth Rate:
58.75%
Total runs:
74
Run Growth:
0
Growth Rate:
0.00%
Total runs:
73
Run Growth:
-207
Growth Rate:
-287.50%
Total runs:
68
Run Growth:
-118
Growth Rate:
-173.53%
Total runs:
66
Run Growth:
0
Growth Rate:
0.00%
Total runs:
62
Run Growth:
24
Growth Rate:
38.71%
Total runs:
61
Run Growth:
-24
Growth Rate:
-40.68%
Total runs:
61
Run Growth:
32
Growth Rate:
53.33%
Total runs:
60
Run Growth:
13
Growth Rate:
20.97%
Total runs:
57
Run Growth:
-3
Growth Rate:
-5.26%
Total runs:
56
Run Growth:
43
Growth Rate:
76.79%
Total runs:
53
Run Growth:
0
Growth Rate:
0.00%
Total runs:
50
Run Growth:
-858
Growth Rate:
-1716.00%
Total runs:
50
Run Growth:
-143
Growth Rate:
-286.00%
Total runs:
50
Run Growth:
27
Growth Rate:
54.00%
Total runs:
48
Run Growth:
-47
Growth Rate:
-97.92%
Total runs:
48
Run Growth:
13
Growth Rate:
26.53%
Total runs:
45
Run Growth:
-7
Growth Rate:
-15.56%
Total runs:
44
Run Growth:
44
Growth Rate:
100.00%
Total runs:
43
Run Growth:
-26
Growth Rate:
-57.78%
Total runs:
43
Run Growth:
-35
Growth Rate:
-81.40%
Total runs:
42
Run Growth:
30
Growth Rate:
71.43%
Total runs:
41
Run Growth:
-24
Growth Rate:
-58.54%
Total runs:
41
Run Growth:
8
Growth Rate:
19.51%
Total runs:
39
Run Growth:
1
Growth Rate:
2.56%
Total runs:
38
Run Growth:
-1
Growth Rate:
-2.56%
Total runs:
36
Run Growth:
-3
Growth Rate:
-8.33%
Total runs:
35
Run Growth:
0
Growth Rate:
0.00%
Total runs:
34
Run Growth:
-1
Growth Rate:
-2.94%
Total runs:
32
Run Growth:
4
Growth Rate:
12.12%
Total runs:
30
Run Growth:
25
Growth Rate:
83.33%
Total runs:
30
Run Growth:
8
Growth Rate:
26.67%
Total runs:
29
Run Growth:
-10
Growth Rate:
-34.48%
Total runs:
29
Run Growth:
17
Growth Rate:
58.62%
Total runs:
28
Run Growth:
15
Growth Rate:
55.56%
Total runs:
27
Run Growth:
13
Growth Rate:
48.15%
Total runs:
26
Run Growth:
16
Growth Rate:
61.54%
Total runs:
26
Run Growth:
0
Growth Rate:
0.00%
Total runs:
25
Run Growth:
13
Growth Rate:
52.00%
Total runs:
25
Run Growth:
-5
Growth Rate:
-19.23%
Total runs:
24
Run Growth:
11
Growth Rate:
45.83%
Total runs:
23
Run Growth:
11
Growth Rate:
47.83%
Total runs:
21
Run Growth:
10
Growth Rate:
45.45%
Total runs:
21
Run Growth:
7
Growth Rate:
33.33%
Total runs:
21
Run Growth:
7
Growth Rate:
33.33%
Total runs:
21
Run Growth:
2
Growth Rate:
9.52%
Total runs:
20
Run Growth:
7
Growth Rate:
33.33%
Total runs:
18
Run Growth:
9
Growth Rate:
50.00%
Total runs:
18
Run Growth:
4
Growth Rate:
22.22%
Total runs:
18
Run Growth:
-8
Growth Rate:
-44.44%
Total runs:
18
Run Growth:
-12
Growth Rate:
-66.67%
Total runs:
18
Run Growth:
6
Growth Rate:
33.33%